Jardiance (empagliflozin) is a prescription SGLT2 inhibitor approved for type 2 diabetes that can cause modest weight loss as a secondary effect. It works by prompting the kidneys to excrete excess glucose in the urine rather than returning it to the bloodstream. Weight loss is a side effect, not the primary purpose of the drug.
Most adults taking Jardiance lose roughly 2% to 3% of their body weight over the first few months of treatment. At 10 mg, clinical trials showed an average loss of 2.8% from baseline weight. At 25 mg, that figure reached 3.2%. For a person weighing 91 kilograms (200 pounds), that translates to roughly 1.8 to 2.7 kilograms (4 to 6 pounds). The placebo group, by comparison, lost only 0.4%.
This article explains the mechanism behind Jardiance-related weight loss, what the clinical evidence actually shows, how it compares to dedicated weight loss drugs, and what safety factors anyone considering it should know. The sections below walk through each question in plain terms.
How Does Jardiance Cause Weight Loss?
What Is Jardiance and How Does It Work in the Body?
Jardiance is the brand name for empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor that blocks a protein in the kidneys responsible for reabsorbing glucose. Under normal conditions, the SGLT2 protein pulls glucose out of urine and back into the bloodstream. Jardiance stops that reabsorption, so glucose leaves the body through urine instead.
This process is called glucosuria. It lowers blood sugar levels, which is the drug’s primary goal for adults with type 2 diabetes. The calorie loss that results from excreting glucose is a secondary effect of that same mechanism.
Because glucose is a fuel source, the body compensates by pulling energy from stored fat. That shift in energy use is one reason users see gradual weight reduction over weeks and months of treatment.
What Are the Three Mechanisms Behind Jardiance Weight Loss?
Jardiance drives weight loss through three overlapping mechanisms: glucose excretion, mild fluid loss, and reduced caloric availability from the bloodstream. Each plays a different role in how and when weight changes appear.
First, glucosuria removes roughly 200 to 300 calories per day in the form of excreted glucose. Over weeks, that caloric deficit accumulates into measurable fat loss. Second, SGLT2 inhibitors have a mild diuretic effect, so early weight drops often include water weight alongside fat loss.
Third, because glucose is exiting through urine rather than circulating in the blood, fewer calories are available for immediate use. The body compensates by drawing on fat stores, reinforcing the slow but steady weight reduction seen in trials.
What Does the Clinical Evidence Show About Jardiance and Weight?
How Much Weight Did Patients Lose in Clinical Trials?
In 24-week clinical trials, patients on Jardiance monotherapy lost between 2% and 3% of their baseline body weight, a result that was statistically significant compared to placebo. The placebo group lost roughly 0.4% over the same period, making the drug’s contribution clear.
For the 10 mg dose, average weight loss was 2.8% from baseline. For the 25 mg dose, it was 3.2%. Participants who added Jardiance to existing metformin therapy saw similar results, with the 10 mg group losing 2.5% and the 25 mg group losing 2.9%.
Those numbers translate to modest real-world amounts. A participant starting at 82 kilograms (180 pounds) on the 25 mg dose would lose roughly 2.4 kilograms (5.3 pounds) over six months, compared to under half a kilogram for the placebo group.
Does Jardiance Work for Weight Loss When Combined With Metformin?
Yes. In a 24-week clinical study involving more than 600 adults, adding Jardiance to an existing metformin regimen produced statistically significant weight loss beyond what metformin alone achieved. Both the 10 mg and 25 mg doses outperformed placebo by roughly 2 percentage points.
Patients on metformin plus placebo lost only about 0.5% of their baseline weight. Those who added 10 mg of Jardiance lost 2.5%, and those who added 25 mg lost 2.9%. The combination approach suggests Jardiance contributes weight loss independently of metformin’s own effects.
How Do the 10 mg and 25 mg Doses Compare for Weight Loss?
The 25 mg dose produces modestly greater weight loss than the 10 mg dose, averaging 3.2% versus 2.8% of baseline body weight in clinical studies. The difference is small but consistent across trials involving both monotherapy and combination therapy.
Doctors typically start patients at 10 mg once daily and may increase to 25 mg if blood sugar control remains inadequate. The dose increase is driven by blood sugar goals, not weight targets. Patients should not request the higher dose solely for weight purposes.
How Much Weight Can You Realistically Lose on Jardiance?
What Does a 2% to 3% Loss Actually Look Like in Real Numbers?
For most adults, a 2% to 3% reduction from baseline body weight on Jardiance translates to roughly 1.8 to 2.7 kilograms (4 to 6 pounds) for someone starting at 91 kilograms (200 pounds). That is a modest but real reduction.
At 68 kilograms (150 pounds), the same percentage means losing 1.4 to 2 kilograms (3 to 4.5 pounds). At 113 kilograms (250 pounds), it means losing 2.3 to 3.4 kilograms (5 to 7.5 pounds). Results cluster in this modest range regardless of starting weight.
The practical takeaway from Eat Proteins’ review of the evidence is that Jardiance is not a significant weight loss tool on its own. It can support a broader program that includes dietary changes and activity, but it should not be the centerpiece of any weight loss plan.
When Does Weight Loss Start and When Does It Plateau?
Weight loss on Jardiance tends to begin gradually in the first few weeks and reaches its peak effect within 3 to 6 months before leveling off. Most of the observable change occurs in this early window.
Initial drops in the first few weeks often include fluid loss from the drug’s mild diuretic effect. As the body adjusts, fat-based loss continues at a slower pace. After 6 months, weight typically stabilizes rather than continuing to fall.
Patients who expect ongoing weight loss beyond that plateau are often disappointed. The drug maintains its blood sugar benefits long term, but the additional caloric deficit from glucosuria does not compound indefinitely over time.
Does Jardiance Affect Appetite or Only Calories?
Does Jardiance Reduce Hunger Like GLP-1 Drugs Do?
No. Jardiance does not directly reduce appetite or hunger signals the way GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) do. Its weight loss mechanism is purely caloric, not hormonal.
GLP-1 drugs act on brain receptors that govern satiety, slowing gastric emptying and reducing the desire to eat. Jardiance has no such effect. People taking it do not typically report feeling less hungry or more full after meals.
That distinction matters for setting expectations. Anyone who has experienced appetite suppression on Ozempic or similar drugs will find that Jardiance works differently and produces a noticeably smaller overall weight reduction for that reason.
Can Changing Diet and Exercise Improve Jardiance Weight Loss Results?
Yes. Diet and physical activity are the primary variables that influence how much weight a person loses while taking Jardiance, since the drug’s own contribution is fixed at roughly 2% to 3%. Adding a caloric deficit through food choices can meaningfully expand total results.
A high-protein diet is one strategy that pairs well with the drug’s mechanism. Protein supports lean mass retention while the body draws on fat stores, which complements the way Jardiance shifts energy sourcing away from circulating glucose.
Exercise, especially resistance training, can further support fat loss while preserving muscle. Jardiance does not interfere with exercise and may support cardiovascular function, making activity a safe addition for most patients under physician supervision.
How Does Jardiance Compare to Other Weight Loss Options?
Does Jardiance Cause Weight Loss Like Ozempic Does?
No. Jardiance produces roughly 2% to 3% body weight reduction, while GLP-1 medications like Ozempic (semaglutide) typically produce 10% to 15% reduction in clinical trials. The difference in magnitude is substantial.
Ozempic and Wegovy achieve greater results partly because they reduce appetite, slow gastric emptying, and affect multiple hormonal pathways. Jardiance acts only through caloric excretion and fluid loss. The two drug classes work through entirely different mechanisms.
Patients who are considering Jardiance primarily for weight loss should discuss that goal directly with their doctor. For someone without type 2 diabetes, Jardiance is not FDA-approved, and the weight outcomes are far smaller than what dedicated anti-obesity medications achieve.
Is Jardiance Prescribed for Weight Loss on Its Own?
No. Jardiance is not FDA-approved for weight loss and should not be prescribed solely for that purpose, regardless of how much weight a patient wants to lose. Its approved uses are type 2 diabetes management, cardiovascular risk reduction, and heart failure hospitalization prevention.
Prescribing it off-label for weight loss in patients without type 2 diabetes falls outside its approval scope. Patients who bring up weight loss as their primary goal are better served by discussing GLP-1 receptor agonists or other dedicated interventions with their physician.
What Are the Side Effects and Safety Risks of Jardiance?
What Are the Most Common Side Effects of Jardiance?
The most common side effects of Jardiance include urinary tract infections, genital yeast infections, increased urination, low blood pressure, and low blood sugar when combined with insulin or sulfonylureas. Most are manageable but worth monitoring.
Genital yeast infections occur because the extra glucose in urine creates conditions that favor fungal growth. Urinary tract infections follow a similar pattern. Patients who experience recurring infections should report them to their prescribing doctor promptly.
Increased urination is a direct result of the glucosuria mechanism and the drug’s mild diuretic effect. Staying well hydrated reduces the risk of low blood pressure and dizziness, particularly in the first weeks of treatment.
What Are the Rare but Serious Risks Associated With Jardiance?
Rare but serious risks with Jardiance include diabetic ketoacidosis, Fournier’s gangrene, and kidney complications that require immediate medical attention if symptoms appear. These events are uncommon but potentially severe.
Diabetic ketoacidosis (DKA) occurs when the body produces excess ketones. It can happen even when blood sugar levels appear normal, which makes it harder to recognize than typical DKA. Symptoms include nausea, vomiting, and abdominal pain.
Fournier’s gangrene is a rare bacterial infection of the genital and perineal area. It is a medical emergency. Patients should seek care immediately for any swelling, redness, or severe pain in that region while taking Jardiance or any SGLT2 inhibitor.
Who Should Not Take Jardiance?
Jardiance is contraindicated for patients with type 1 diabetes, severe kidney disease, and those who are pregnant, as the risks in these groups outweigh any potential benefit. These are hard exclusions, not cautions to weigh against other factors.
People with moderate kidney impairment may still take Jardiance for its heart failure or cardiovascular benefits, but the blood sugar lowering effect diminishes as kidney function declines. Dosing decisions in kidney disease require specialist input.
Anyone currently on dialysis or with an eGFR below the threshold set in current prescribing guidelines should not use Jardiance for glucose control. A nephrologist and endocrinologist should coordinate care in borderline cases.
Does Everyone Lose Weight on Jardiance?
What Factors Influence Whether Jardiance Causes Weight Loss?
Weight loss on Jardiance varies by individual and is shaped by factors including diet, physical activity levels, other medications, baseline metabolic rate, and kidney function. Not every person taking the drug will see a measurable change on the scale.
Patients eating a high-calorie diet may offset the 200 to 300 calories per day lost through glucosuria without realizing it. The drug creates a caloric deficit only if total intake stays roughly the same. Overeating can erase the benefit entirely.
Kidney function also plays a role. As kidney function decreases, the SGLT2 mechanism becomes less effective, which reduces the volume of glucose excreted and limits the associated caloric loss. Patients with reduced kidney function may see little to no weight change.
Can Jardiance Cause Too Much Weight Loss?
Significant or excessive weight loss from Jardiance alone is unlikely given that the drug produces only 2% to 3% total body weight reduction on average, a range that is too small to cause underweight or nutritional deficiency in most adults.
Patients who are already at a low body weight or who have conditions that affect nutrient absorption should discuss that context with their physician before starting the drug. In those cases, even modest additional weight loss could be clinically relevant.
If a patient on Jardiance is losing weight faster than expected or feels unwell alongside the weight loss, they should check in with their doctor. Rapid unexplained loss can indicate ketoacidosis or another complication rather than the drug’s typical effect.
Want a Free Eat Proteins Weight Loss Guide That Works With Your Medications?
Jardiance can move the needle slightly on weight, but the real results come from pairing it with a structured nutrition plan. Eat Proteins offers a free guide that shows how to build a high-protein eating approach that complements medications like Jardiance without fighting the biology behind them.
The guide covers how much protein supports fat loss while preserving muscle, which food combinations keep blood sugar stable, and how to structure meals around an active day. It’s built for people managing type 2 diabetes or metabolic conditions who want practical steps, not vague advice.
If you’re already on Jardiance or discussing it with your doctor, having a solid nutrition foundation in place makes every percentage point of weight loss count more. You can also explore this resource on sustainable weight management strategies that work alongside diabetes medications.